The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome
- PMID: 16610945
- DOI: 10.2217/14622416.7.3.345
The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome
Abstract
Chronic fatigue syndrome (CFS) is a debilitating illness characterized by multiple unexplained symptoms including fatigue, cognitive impairment and pain. People with CFS have no characteristic physical signs or diagnostic laboratory abnormalities, and the etiology and pathophysiology remain unknown. CFS represents a complex illness that includes alterations in homeostatic systems, involves multiple body systems and results from the combined action of many genes, environmental factors and risk-conferring behavior. In order to achieve understanding of complex illnesses, such as CFS, studies must collect relevant epidemiological, clinical and laboratory data and then integrate, analyze and interpret the information so as to obtain meaningful clinical and biological insight. This issue of Pharmacogenomics represents such an approach to CFS. Data was collected during a 2-day in-hospital study of persons with CFS, other medically and psychiatrically unexplained fatiguing illnesses and nonfatigued controls identified from the general population of Wichita, KS, USA. While in the hospital, the participants' psychiatric status, sleep characteristics and cognitive functioning was evaluated, and biological samples were collected to measure neuroendocrine status, autonomic nervous system function, systemic cytokines and peripheral blood gene expression. The data generated from these assessments was made available to a multidisciplinary group of 20 investigators from around the world who were challenged with revealing new insight and algorithms for integration of this complex, high-content data and, if possible, identifying molecular markers and elucidating pathophysiology of chronic fatigue. The group was divided into four teams with representation from the disciplines of medicine, mathematics, biology, engineering and computer science. The papers in this issue are the culmination of this 6-month challenge, and demonstrate that data integration and multidisciplinary collaboration can indeed yield novel approaches for handling large, complex datasets, and reveal new insight and relevance to a complex illness such as CFS.
Comment in
-
The postgenomic era and complex disease.Pharmacogenomics. 2006 Apr;7(3):341-3. doi: 10.2217/14622416.7.3.341. Pharmacogenomics. 2006. PMID: 16610944 No abstract available.
Similar articles
-
Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.Genes Brain Behav. 2007 Mar;6(2):167-76. doi: 10.1111/j.1601-183X.2006.00244.x. Genes Brain Behav. 2007. PMID: 16740143
-
Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.Psychosom Med. 2009 Jun;71(5):549-56. doi: 10.1097/PSY.0b013e3181a4fea8. Epub 2009 May 4. Psychosom Med. 2009. PMID: 19414615
-
Gene expression profile exploration of a large dataset on chronic fatigue syndrome.Pharmacogenomics. 2006 Apr;7(3):429-40. doi: 10.2217/14622416.7.3.429. Pharmacogenomics. 2006. PMID: 16610953
-
Challenges for molecular profiling of chronic fatigue syndrome.Pharmacogenomics. 2006 Mar;7(2):211-8. doi: 10.2217/14622416.7.2.211. Pharmacogenomics. 2006. PMID: 16515400 Review.
-
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.BMC Health Serv Res. 2003 Dec 31;3(1):25. doi: 10.1186/1472-6963-3-25. BMC Health Serv Res. 2003. PMID: 14702202 Free PMC article. Review.
Cited by
-
Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data.J Transl Med. 2006 Aug 15;4:34. doi: 10.1186/1479-5876-4-34. J Transl Med. 2006. PMID: 16911783 Free PMC article.
-
Identification of marker genes for differential diagnosis of chronic fatigue syndrome.Mol Med. 2008 Sep-Oct;14(9-10):599-607. doi: 10.2119/2007-00059.Saiki. Mol Med. 2008. PMID: 18596870 Free PMC article.
-
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome.BMC Syst Biol. 2008 Nov 6;2:95. doi: 10.1186/1752-0509-2-95. BMC Syst Biol. 2008. PMID: 18986552 Free PMC article.
-
Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.Behav Brain Funct. 2008 Sep 26;4:44. doi: 10.1186/1744-9081-4-44. Behav Brain Funct. 2008. PMID: 18822143 Free PMC article.
-
Prediction of complex human diseases from pathway-focused candidate markers by joint estimation of marker effects: case of chronic fatigue syndrome.Hum Genomics. 2015 Jun 11;9(1):8. doi: 10.1186/s40246-015-0030-6. Hum Genomics. 2015. PMID: 26063326 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical